Aptorum Group Ltd
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
APM | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG6096M1069
- LEI:
- Country:
- United States of America
- Address:
- 17 HANOVER SQUARE, LONDON
- Website:
- https://www.aptorumgroup.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aptorum Group Limited is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutic assets. The company focuses on addressing unmet medical needs across various disease areas, with a particular emphasis on orphan oncology, infectious diseases, metabolic diseases, and women's health. Aptorum Group aims to advance medical innovations by developing treatments for challenging health conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aptorum Group Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aptorum Group Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aptorum Group Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
